Sonendo® Announces Next Generation GentleWave® G4 System
October 18 2022 - 7:00AM
Business Wire
Designed to Improve Patient Workflow, the
GentleWave G4 System Is the Latest Innovation from Sonendo
Sonendo, Inc. (NYSE: SONX), a leading dental technology company
and developer of the GentleWave® System, today announced the
release of the GentleWave G4 System, the next generation of its
innovative technology platform designed to treat tooth decay. With
Sonendo's patented technology at its core, the GentleWave G4 System
is designed for an optimized doctor and patient experience with a
refined, simplified workflow – all while delivering the enhanced
level of clean that is only available with GentleWave Technology.
Broad-spectrum acoustic energy and advanced fluid dynamics deliver
advanced disinfection to penetrate even the most complex anatomies,
resulting in a predictable and superior level of cleaning and
improved healing time.
Since its inception, the GentleWave Procedure has redefined the
standard of root canal treatment with a minimally invasive process
that preserves tooth structure and promotes early healing.
According to a recent clinical trial, 99.5% of patients experienced
minimal to no pain during the GentleWave Procedure with the
addition of CleanFlow™ Technology.
Closely following the launch of CleanFlow Technology in April of
this year, the GentleWave G4 System marks the latest innovation
from Sonendo and is a testament to the Company's continued
investment in dental technology and the specialty of
endodontics.
"The GentleWave G4 System highlights our commitment to
world-class innovation. Our new console has a modern look, is
highly effective, and built for the future of endodontics by being
software upgradeable and ready to accept future technical
innovations from Sonendo. It is a direct result of listening to our
practitioners' needs and addressing them through product
innovation," said Bjarne Bergheim, President and CEO of Sonendo.
"With a mission to save teeth and improve lives, we are proud to
introduce this next generation GentleWave System to the market – a
testament to our commitment to elevating patient care and practice
workflow. We are truly transforming how root canals are
performed."
The GentleWave G4 System was created with future software
adaptations and evolving features in mind. An intuitive,
user-friendly interface provides step-by-step guidance for
practitioners and auditory cues that improve procedure awareness
reducing the need to look away from the patient during treatment.
Battery backup and high-capacity fluid reservoirs decrease downtime
between treatments and allow up to six procedures before refilling
fluids. The system also allows multi-operatory connectivity, which
means doctors can monitor multiple systems across their office,
leading to improved workflow efficiency.
"Since adopting the GentleWave System, I have seen heightened
productivity within my practice and more successful root canal
procedures," said Rick Simcock, DDS, an endodontist based in
Bellingham, Washington and a user of the GentleWave System. "I am
confident that this next iteration will bring even more
efficiencies, as the larger fluid capacity and new battery backup
significantly cut down on system preparation time between
procedures. The GentleWave G4 System is further evidence of
Sonendo's investment in my practice and the broader specialty."
The GentleWave G4 System will be showcased at EndoCon®,
Sonendo's second annual endodontic conference on innovation, taking
place in San Diego from Oct. 20-22.
For more information about Sonendo and the GentleWave G4 System,
or to register interest in it, please visit
www.gentlewave.com/doctor/G4. To find a GentleWave doctor in your
area, please visit www.gentlewave.com.
About Sonendo
Sonendo is a commercial-stage medical technology company focused
on saving teeth from tooth decay, the most prevalent chronic
disease globally. Sonendo developed and manufactured the
GentleWave® System, an innovative technology platform designed to
treat tooth decay by cleaning and disinfecting the microscopic
spaces within teeth without the need to remove tooth structure. The
system utilizes a proprietary mechanism of action, which combines
procedure fluid optimization, broad-spectrum acoustic energy, and
advanced fluid dynamics, to debride and disinfect deep regions of
the complex root canal system in a less invasive procedure that
preserves tooth structure. The clinical benefits of the GentleWave
System when compared to conventional methods of root canal therapy
include improved clinical outcomes, such as superior cleaning that
is independent of root canal complexity and tooth anatomy, high and
rapid rates of healing and minimal to no post-operative pain. In
addition, the GentleWave System can improve the workflow and
economics of dental practices and offers patients an effective,
less invasive, and less painful alternative to traditional root
canal therapy.
Sonendo is also the parent company of TDO® Software, Inc., the
developer of widely used endodontic practice management software
solutions, designed to simplify practice workflow. TDO Software
integrates practice management, imaging, referral reporting and
CBCT imaging, and offers built-in communication with the GentleWave
System.
For more information about Sonendo and the GentleWave System,
please visit www.gentlewave.com/doctor/G4. To find a GentleWave
doctor in your area, please visit www.gentlewave.com.
Forward Looking Statements
This press release contains "forward-looking statements" based
on Sonendo's current expectations, forecasts and beliefs including
statements related to the general release of the GentleWave G4
System. These forward-looking statements are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Actual outcomes and results could differ materially due to
a number of factors, including the ongoing uncertainty of the
impact of the COVID-19 pandemic, as well as COVID recovery impact,
on its business. These and other risks and uncertainties include
those described more fully in the Company's Annual Report on Form
10-K for the year ended December 31, 2021 filed with the Securities
and Exchange Commission (the "SEC") on March 23, 2022, Quarterly
Reports on Form 10-Q for the quarters ended March 31, 2022 and June
30, 2022 filed with the SEC on May 10, 2022 and August 10, 2022,
respectively, under the sections titled "Risk Factors" and
"Management's Discussion and Analysis of Financial Condition and
Results of Operations," as well as any reports that Sonendo may
file with the SEC in the future. Forward-looking statements
contained in this announcement are based on information available
to Sonendo as of the date hereof. Sonendo undertakes no obligation
to update such information except as required under applicable law.
These forward-looking statements should not be relied upon as
representing Sonendo's views as of any date subsequent to the date
of this press release and should not be relied upon as prediction
of future events. In light of the foregoing, investors are urged
not to rely on any forward-looking statement in reaching any
conclusion or making any investment decision about any securities
of Sonendo. GENTLEWAVE and ENDOCON are trademarks of Sonendo,
Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221018005231/en/
Sarah Gallagher Crowe PR sgallagher@crowepr.com (224)
406-4709
Greg Chodaczek Gilmartin Group greg@gilmartinir.com or,
ir@sonendo.com
Sonendo (NYSE:SONX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sonendo (NYSE:SONX)
Historical Stock Chart
From Apr 2023 to Apr 2024